Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma

Uveal melanoma is the most common primary ocular malignancy in adults, characterized by gene mutations in G protein subunit alpha q (<i>GNAQ</i>) and G protein subunit alpha 11 (<i>GNA11</i>). Although they are considered to be driver mutations, their role in MUM remains elus...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mizue Terai, Ayako Shimada, Inna Chervoneva, Liam Hulse, Meggie Danielson, Jeff Swensen, Marlana Orloff, Philip B. Wedegaertner, Jeffrey L. Benovic, Andrew E. Aplin, Takami Sato
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/86a4c271f81742bab04b74ded1bf5119
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Uveal melanoma is the most common primary ocular malignancy in adults, characterized by gene mutations in G protein subunit alpha q (<i>GNAQ</i>) and G protein subunit alpha 11 (<i>GNA11</i>). Although they are considered to be driver mutations, their role in MUM remains elusive. We investigated key somatic mutations of MUM and their impact on patients’ survival after development of systemic metastasis (Met-to-Death). Metastatic lesions from 87 MUM patients were analyzed by next generation sequencing (NGS). <i>GNA11</i> (41/87) and <i>GNAQ</i> (39/87) mutations were most predominantly seen in MUM. Most <i>GNA11</i> mutations were Q209L (36/41), whereas <i>GNAQ</i> mutations comprised Q209L (14/39) and Q209P (21/39). Epigenetic pathway mutations <i>BAP1</i> (42/66), <i>SF3B1</i> (11/66), <i>FBXW7</i> (2/87), <i>PBRM1</i> (1/66), and <i>SETD2</i> (1/66) were found. No specimen had the EIF1AX mutation. Interestingly, Met-to-Death was longer in patients with <i>GNAQ</i> Q209P compared to <i>GNAQ/GNA11</i> Q209L mutations, suggesting the difference in mutation type in <i>GNAQ/GNA11</i> might determine the prognosis of MUM. Structural alterations of the GNAQ/GNA11 protein and their impact on survival of MUM patients should be further investigated.